We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Possible New Treatment for Neurodegenerative Diseases Found
News

Possible New Treatment for Neurodegenerative Diseases Found

Possible New Treatment for Neurodegenerative Diseases Found
News

Possible New Treatment for Neurodegenerative Diseases Found

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Possible New Treatment for Neurodegenerative Diseases Found"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Neurodegeneration involves the progressive loss of nerve structure and function and is a common characteristic of several conditions, including Parkinson’s, Alzheimer’s and Huntington’s. Such diseases are presently incurable.

Researchers from the University’s Institute of Translational Medicine have found that the anti-epileptic drug ethosuximide has protective effects in certain neurodegenerative disease models.

Making a difference

Professor of Cellular and Molecular Physiology, Alan Morgan, said: “Incidence of these diseases is on the rise due to our increasingly ageing population, yet there is a lack of effective therapies to treat them.

“Our research suggests that ethosuximide has potential for repurposing as a treatment for multiple neurodegenerative diseases and provides a platform from which new medicines could be developed.

“Indeed, we are now actively pursuing this in current research with colleagues Professor Bob Burgoyne and PhD student, Shi Quan Wong. Eventually, we hope that our work will make a difference to those suffering from these debilitating diseases.”

The study was funded by grants from the BBSRC, the Wellcome Trust and Age UK.

Advertisement